SIERRA ONCOLOGY INC's ticker is SRRA and the CUSIP is 82640U107. A total of 51 filers reported holding SIERRA ONCOLOGY INC in Q4 2017. The put-call ratio across all filers is - and the average weighting 0.4%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q1 2019 | $67,000 | -8.2% | 39,066 | -29.3% | 0.00% | – |
Q4 2018 | $73,000 | -97.0% | 55,291 | -96.1% | 0.00% | -100.0% |
Q3 2018 | $2,404,000 | -63.8% | 1,413,995 | -37.0% | 0.00% | -66.7% |
Q2 2018 | $6,639,000 | +40.7% | 2,242,883 | -1.6% | 0.01% | +50.0% |
Q1 2018 | $4,720,000 | +3.6% | 2,280,430 | +86.6% | 0.01% | 0.0% |
Q4 2017 | $4,558,000 | +208.8% | 1,221,856 | +28.3% | 0.01% | +200.0% |
Q3 2017 | $1,476,000 | +3040.4% | 952,015 | +2245.7% | 0.00% | – |
Q2 2017 | $47,000 | -72.7% | 40,586 | -63.9% | 0.00% | – |
Q1 2017 | $172,000 | – | 112,500 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
FRAZIER MANAGEMENT LLC | 8,112,121 | $10,708,000 | 2.76% |
New Leaf Venture Partners, L.L.C. | 5,020,446 | $6,627,000 | 1.82% |
Prosight Management, LP | 2,553,943 | $3,371,000 | 1.74% |
Abingworth LLP | 1,444,445 | $1,892,000 | 1.72% |
Broadfin Capital, LLC | 4,880,327 | $6,442,000 | 0.85% |
MANGROVE PARTNERS IM, LLC | 3,688,609 | $4,869,000 | 0.65% |
Vivo Capital, LLC | 2,438,270 | $3,219,000 | 0.41% |
PA Capital LLC | 138,752 | $183,000 | 0.19% |
683 Capital Management, LLC | 2,173,620 | $2,869,000 | 0.17% |
ARMISTICE CAPITAL, LLC | 1,600,000 | $2,112,000 | 0.16% |